Glioma
📧 Sign up to get email alerts when something new happens for Glioma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-02-28Clinical Trial Update: Thalidomide and Temozolomide or Camptothecin-11 (CPT-11) in Patients With Gliomas [Phase 2]
A Phase 2 trial evaluating thalidomide with temozolomide or with Camptothecin-11 (irinotecan) in gliomas has completed and results were post…
-
CLINICAL_TRIALS trial_result · 2012-02-24Clinical Trial Update: Determination of Fraction Size Equivalent Dose (FED) Levels for Intracranial Conformal Avoidance Radiotherapy
A completed clinical trial update describes the determination of fraction size equivalent dose (FED) levels for intracranial conformal avoid…
-
CLINICAL_TRIALS trial_result · 2012-02-17Clinical Trial Update: Combination of Irinotecan and Temozolomide in Children With Brain Tumors. [Phase 2]
Phase 2 trial evaluating the combination of irinotecan and temozolomide in children with brain tumors (glioma and medulloblastoma) has compl…
-
CLINICAL_TRIALS trial_result · 2012-02-09Clinical Trial Update: A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma [Phase 2]
This Phase II study evaluating temozolomide in combination with O6-benzylguanine for temozolomide-resistant anaplastic glioma was terminated…
-
CLINICAL_TRIALS research · 2012-02-07Clinical Trial Update: Gene Expression, Immunological Status and Metabolome in Glioma Patients
An ongoing study from the National Institute of Biology, Slovenia investigates gene expression, immune status, and metabolomics in patients …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-12-09Clinical Trial Update: Phase II Study of Irinotecan HCI for Recurrent Anaplastic Astrocytomas, Mixed Malignant Gliomas, and Oligodendrogliomas [Phase 2]
Phase II trial of irinotecan hydrochloride in recurrent anaplastic astrocytoma, mixed malignant glioma, and oligodendroglioma was terminated…
-
CLINICAL_TRIALS trial_result · 2011-10-26Clinical Trial Update: Phase II Trial of Peginterferon Alpha-2b and Thalidomide in Adults With Recurrent Gliomas [Phase 2]
Phase II trial of peginterferon alpha-2b plus thalidomide in adults with recurrent gliomas has completed, with results posted.
-
CLINICAL_TRIALS trial_result · 2011-09-29Clinical Trial Update: Advanced MR Techniques in Detection of Tumor Infiltration and Grading in Gliomas
This update reports on a completed clinical trial evaluating advanced MRI techniques to detect tumor infiltration and grading in glioma pati…
-
CLINICAL_TRIALS trial_result · 2011-08-09Clinical Trial Update: O6-Benzylguanine and Temozolomide in Treating Young Patients With Recurrent or Progressive Gliomas or Brain Stem Tumors [Phase 2]
Phase 2 clinical trial evaluating O6-Benzylguanine with Temozolomide in young patients with recurrent or progressive gliomas or brain stem t…
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: Bevacizumab and Irinotecan for Patients With Primary Brain Tumors and Progression After Standard Therapy [Phase 2]
Phase 2 trial of bevacizumab plus irinotecan for patients with primary brain tumors has completed enrollment and status is updated.
-
CLINICAL_TRIALS trial_result · 2011-06-29Clinical Trial Update: Low-dose Temozolomide for 2 Weeks on Brain Tumor Enzyme in Patients With Gliomas (P04602 AM1) (Completed) [Phase 2]
This update reports the completion of a Phase 2 trial evaluating low-dose temozolomide given for two weeks in patients with glioma; results …
-
CLINICAL_TRIALS research · 2011-06-27Clinical Trial Update: Cell Culture of Glioma Specimens for in Vitro Preclinical Studies
Albany Medical College is conducting a trial to culture glioma specimens for in vitro preclinical studies to advance brain tumor research.
-
CLINICAL_TRIALS trial_result · 2011-04-22Clinical Trial Update: Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas [Phase 1]
A Phase 1 trial assessed arsenic trioxide combined with radiation therapy in children with newly diagnosed gliomas. The study has completed …
-
CLINICAL_TRIALS research · 2011-04-12Clinical Trial Update: Establishment of a Brain and Spinal Tumor Tissue Bank
Clinical trial update describing the establishment of a brain and spinal tumor tissue bank sponsored by Taipei Medical University WanFang Ho…
-
CLINICAL_TRIALS trial_result · 2011-01-14Clinical Trial Update: Study of Aminolevulinic Acid to Enhance Visualization and Resection of Malignant Glial Tumors of the Brain [Phase 1]
Phase 1 trial evaluating aminolevulinic acid to enhance visualization and surgical resection of malignant glial brain tumors; the study has …
-
CLINICAL_TRIALS trial_result · 2010-06-11Clinical Trial Update: High Light and Low Light Dose PDT in Glioma [Phase 3]
A Phase 3 trial comparing high light-dose versus low light-dose photodynamic therapy in glioma has completed.
-
CLINICAL_TRIALS trial_result · 2010-05-17Clinical Trial Update: The Effects of Continuous 28-day (28/28) Temozolomide Chemotherapy in Subjects With Recurrent Malignant Glioma Who Have Failed the Conventional 5-day (5/28) Treatment (P04601) [Phase 2]
Phase 2 trial evaluating continuous 28-day temozolomide in patients with recurrent malignant glioma who failed the standard 5-day regimen; r…
-
CLINICAL_TRIALS trial_result · 2010-04-09Clinical Trial Update: Imatinib Mesylate With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed or Recurrent Glioma [Phase 1, Phase 2]
This clinical trial evaluated imatinib mesylate with or without radiation therapy in children with newly diagnosed or recurrent glioma; the …
-
CLINICAL_TRIALS research · 2010-02-24Clinical Trial Update: Safety and Effectiveness Study of Autologous Natural Killer and Natural Killer T Cells on Cancer [Phase 1]
Phase 1 safety and effectiveness study of autologous natural killer and natural killer T cell therapy for multiple cancers is currently susp…
-
CLINICAL_TRIALS trial_result · 2010-01-20Clinical Trial Update: A Phase II Study Of Gliadel, Concomitant Temozolomide And Radiation, Followed By Dose Dense Therapy With Temozolomide Plus Bevacizumab For Newly Diagnosed Malignant High Grade Glioma [Phase 2]
A Phase II study evaluates Gliadel wafers with temozolomide and radiation, followed by dose-dense temozolomide plus bevacizumab, for newly d…
-
CLINICAL_TRIALS trial_result · 2010-01-20Clinical Trial Update: A Phase II Study of Gliadel, Concomitant Temozolomide and Radiation, Followed By Dose Dense Therapy With Temozolomide For Newly Diagnosed Malignant High Grade Glioma [Phase 2]
A Phase II clinical trial is evaluating Gliadel implants with concurrent temozolomide and radiation, followed by dose-dense temozolomide, fo…
-
CLINICAL_TRIALS trial_result · 2010-01-20Clinical Trial Update: Genetic Epidemiology of Adult Onset Glioma
This clinical trial update reports the completion of a genetic epidemiology study investigating risk factors for adult-onset glioma.
-
CLINICAL_TRIALS trial_result · 2009-10-14Clinical Trial Update: Carboplatin in Patients With Progressive Gliomas [Phase 2]
Phase 2 clinical trial evaluating carboplatin in patients with progressive gliomas has completed. The update provides information on the tri…
-
CLINICAL_TRIALS research · 2009-09-15Clinical Trial Update: Comparison of Neuro-navigational Systems for Resection-Control of Brain Tumors [NA]
This clinical trial update compares neuro-navigational systems used to guide brain tumor resections in glioma, with the current status liste…
-
CLINICAL_TRIALS trial_result · 2009-04-03Clinical Trial Update: A Study of Motexafin Gadolinium and Temozolomide for the Treatment of Malignant Gliomas [Phase 1]
Phase 1 study evaluating the combination of motexafin gadolinium and temozolomide in malignant gliomas has completed.